MYC and neoplasm: In light of our data presented here, work by Amaravadi and colleagues lends further support to targeting Myc as an anti-neoplatic strategy, especially in Myc-induced tumours, as this might confer the additional benefit of inhibiting autophagy in the case of therapy resistance associated with chemotherapy-induced autophagy.